Nephros (NEPH) Return on Capital Employed (2011 - 2026)
Nephros' quarterly Return on Capital Employed came in at 6.05% in Q1 2026, down 169.0% year-on-year from 8.77% in Q1 2025, and down 43.64% quarter-over-quarter from 10.73% in Q4 2025.
Nephros has reported Return on Capital Employed for 16 years, with the latest figure at 6.05% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed fell 169.0% year-over-year to 6.05%; the trailing twelve-month figure through Mar 2026 stood at 6.05% (down 169.0% YoY), and the FY2025 full-year result was 11.87%, up 1181.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 6.05%, down from 10.73% in the prior quarter.
- The five-year high for Return on Capital Employed was 14.06% in Q3 2025, with the low at 44.44% in Q4 2022.
- Average Return on Capital Employed over 5 years is 13.23%, with a median of 15.31% recorded in 2024.
- Year-over-year, Return on Capital Employed slumped 2060 bps in 2022 and jumped 2777 bps in 2025.
- Tracing NEPH's Return on Capital Employed over 5 years: stood at 44.44% in 2022, then surged by 61 bps to 17.17% in 2023, then soared by 100 bps to 0.06% in 2024, then soared by 16422 bps to 10.73% in 2025, then tumbled by 44 bps to 6.05% in 2026.
- The last three Return on Capital Employed figures came in at 6.05% (Q1 2026), 10.73% (Q4 2025), and 14.06% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 17.54% |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 5.02% |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 25.95% |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 18.63% |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 19.44% |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 6.60% |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 12.74% |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 13.02% |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 12.04% |
| 10 | Nephros | 38.93 Mn | 34.91 Mn | 2.99 Mn | 6.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.05% |
| Dec 31, 2025 | 10.73% |
| Sep 30, 2025 | 14.06% |
| Jun 30, 2025 | 13.06% |
| Mar 31, 2025 | 7.74% |
| Dec 31, 2024 | 0.06% |
| Sep 30, 2024 | -9.91% |
| Jun 30, 2024 | -14.71% |
| Mar 31, 2024 | -15.31% |
| Dec 31, 2023 | -17.17% |
| Sep 30, 2023 | -18.55% |
| Jun 30, 2023 | -28.70% |
| Mar 31, 2023 | -32.40% |
| Dec 31, 2022 | -44.44% |
| Sep 30, 2022 | -37.63% |
| Jun 30, 2022 | -29.58% |
| Mar 31, 2022 | -28.21% |
| Dec 31, 2021 | -23.84% |
| Sep 30, 2021 | -22.73% |
| Jun 30, 2021 | -23.97% |
| Mar 31, 2021 | -25.38% |
| Dec 31, 2020 | -27.49% |
| Sep 30, 2020 | -28.36% |
| Jun 30, 2020 | -24.55% |
| Mar 31, 2020 | -24.30% |
| Dec 31, 2019 | -34.43% |
| Sep 30, 2019 | -41.45% |
| Jun 30, 2019 | -43.79% |
| Mar 31, 2019 | -44.13% |
| Dec 31, 2018 | -41.16% |
| Sep 30, 2018 | -40.24% |
| Jun 30, 2018 | -62.11% |
| Mar 31, 2018 | -89.19% |
| Dec 31, 2017 | -109.52% |
| Sep 30, 2017 | -171.21% |
| Jun 30, 2017 | -119.37% |
| Mar 31, 2017 | -121.36% |
| Dec 31, 2016 | -147.20% |
| Sep 30, 2016 | -113.39% |
| Jun 30, 2016 | -146.25% |
| Mar 31, 2016 | -131.93% |
| Dec 31, 2015 | -107.69% |
| Sep 30, 2015 | -121.37% |
| Jun 30, 2015 | -174.79% |
| Mar 31, 2015 | -167.46% |
| Dec 31, 2014 | -134.12% |
| Sep 30, 2014 | 898.33% |
| Jun 30, 2014 | -281.74% |
| Mar 31, 2014 | -421.44% |
| Dec 31, 2013 | 427.04% |
| Sep 30, 2013 | -436.41% |
| Jun 30, 2013 | -321.37% |
| Mar 31, 2013 | 491.88% |
| Dec 31, 2012 | -1,022.39% |
| Sep 30, 2012 | -204.36% |
| Jun 30, 2012 | -158.88% |
| Mar 31, 2012 | -90.48% |
| Dec 31, 2011 | -102.10% |
| Sep 30, 2011 | -125.75% |